Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
net/publication/6840550
CITATIONS READS
98 2,099
3 authors, including:
Michael Gold
University of Adelaide
106 PUBLICATIONS 2,808 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Combined probiotic and peanut oral immunotherapy for the treatment of peanut allergy View project
All content following this page was uploaded by Michael Gold on 20 September 2014.
2. Anaphylaxis:
diagnosis and management
Simon G A Brown, Raymond J Mullins and Michael S Gold
Ancillary medications Flushing and oedema can be transient, subtle and easily
overlooked. Sometimes the only clue may be “normal” (warm,
Medications such as antihistamines, H2 receptor antagonists, well perfused) skin in the setting of circulatory collapse, when pallor
corticosteroids and antileukotrienes have no proven impact on the and poor perfusion would be the norm. In cases of acute-onset
immediate and dangerous effects of anaphylaxis, although they bronchospasm or hypotension, look carefully for these features
may ameliorate mild allergic reactions confined to the skin. The and ask relatives or friends if they have noticed any changes.
only registered antihistamine for parenteral use in Australia, (Reproduced with permission from the patient.) ◆
promethazine, can worsen vasodilation and hypotension, and its
fatalities associated with anaphylaxis occur in of inducing anaphylaxis, they should only be
5 Differential diagnosis of
these patients.1 carried out in an environment in which
anaphylaxis
Poorly controlled asthma is the main risk resources for treating anaphylaxis are available.
factor for death in children. Age over 35 years Tissue swelling Measurement of total IgE and in-vitro testing
and previous severe reactions are the main risk • Idiopathic urticaria using food mixes frequently provide misleading
factors for hypotension and death in adults. • Isolated angioedema* or irrelevant results and should not be
• Idiopathic requested.
• ACE inhibitor-induced There is currently no test to confirm tick bite
After the acute episode allergy. Skin testing for jack jumper ant allergy
• Acquired or hereditary C1 esterase
Before examining the surrounding circum- is not yet available outside the Royal Hobart
inhibitor deficiency
stances to define a cause for the patient’s symp- Hospital in Tasmania, although an in-vitro test
Conditions mimicking upper airway
toms (Box 2), it is important to first determine is available from SouthPath Laboratories in
oedema
whether anaphylaxis occurred by carefully South Australia (this detects only 80% of cases,
reviewing the available documentation. Short- • Dystonic reactions mimicking
and, while the subject of ongoing research,
symptoms of a swollen tongue
lived bouts of urticaria and/or angioedema last- after taking metoclopramide, there is no validated test to detect allergy to
ing less than 12 hours should prompt suspicion prochlorperazine or antihistamines related ant species).
of an allergic cause, although on their own they Some drug reactions (eg, to NSAIDS, radio-
• Acute oesophageal reflux (sudden
do not satisfy a definition of anaphylaxis. As onset of painful throat “swelling”) graphic contrast agents) are independent of IgE,
typical cutaneous features may be absent in up and there are numerous difficulties in assessing
Flushing syndromes
to 20% of cases, anaphylaxis should be consid- some cases of antibiotic allergy. To establish a
• Peptide-secreting tumours (eg,
ered in the differential diagnosis of any episode diagnosis in cases in which the causative agent
carcinoid syndrome, VIPomas†)
of severe, acute-onset respiratory distress, bron- is in doubt, challenge testing under controlled
chospasm or cardiovascular collapse (Box 9). • Alcohol-related
conditions may sometimes be required,
Details of exposure to potential triggers, • Medullary carcinoma of thyroid although a negative challenge test does not
including occupational allergens (eg, latex) and • “Red man syndrome”‡ always exclude the diagnosis.
cofactors, in the preceding 8 hours should be Neurological syndromes There is no scientific validity for “alternative”
recorded while memory of the event is fresh. • Epileptic seizure therapies such as cytotoxic or Vega testing, hair
Almost all anaphylactic reactions to insect ven- • Stroke analysis and kinesiology, and their use should
oms or to food or medication occur within 1 and Other causes of collapse
be discouraged.34
6 hours, respectively.2
• Vasovagal episodes
Medical practitioners should record the pres-
• Systemic inflammatory response Long-term management
ence of known food or drug hypersensitivity and
syndrome Anaphylaxis to insect stings can be prevented
consider the possibility of accidental exposure.
Ask patients about symptoms of contact urticaria • Shock (septic, cardiogenic, with venom immunotherapy,23 which reduces
haemorrhagic) the risk of anaphylaxis from repeated stings
(eg, during food preparation) or itching in the
mouth and throat after eating certain foods (oral Acute respiratory distress and is associated with an improved quality of
allergy syndrome). The latter indicates an allergy • Asthma life compared with carrying an EpiPen alone.24
to structurally similar proteins in pollen and in • Panic disorders Attempts to modify the severity of food allergy
some fruit and vegetables.2 If an insect sting has • Globus hystericus using similar techniques have thus far failed,
occurred, factors that may help identify the although novel methods of inducing tolerance
• Laryngospasm
cause are the insect’s appearance, the presence of hold some promise for the future.35
• Vocal cord dysfunction
a stinger left in the skin (pathognomonic for For most patients, anaphylaxis is a disorder
Miscellaneous for which the risk of relapse is chronic but the
honeybee sting) and the location where the sting
occurred (stings by jack jumper ants or bulldog
• Scombroid fish poisoning event itself is unpredictable.2 The mainstays of
ants are more common in bushland). • Serum sickness long-term management of anaphylaxis
• Phaeochromocytoma include:
Investigation • (Systemic mastocytosis§) • Specialist assessment.
In-vitro testing for allergen-specific IgE (using a • Identification and avoidance of triggers and
ACE = angiotensin-converting enzyme.
radioallergosorbent test [RAST] or ImmunoCAP * Isolated angioedema lacks any other cofactors, if possible. Common triggers of
[Phadia AB, Uppsala, Sweden]) is a useful initial organ or systemic features and thus by anaphylaxis include food, stinging insects and
screening test for a variety of allergens. In-vitro
definition is not anaphylaxis. medication. Exercise, alcohol consumption
† Neuroendocrine tumours that secrete and taking NSAIDS are common cofactors.
testing has limitations because the test lacks vasoactive intestinal polypeptide. ‡ “Red
sensitivity and is limited by the range of aller- man syndrome” is flushing and erythema • Avoidance of medications that may compli-
gens available and the ability to claim Medicare associated with infusion of vancomycin (or cate management.
occasionally other antibiotics). It is thought • Training patients to recognise early warn-
rebates for only four allergens at a time. to be due to histamine release, and may
Skin prick testing, to assess sensitisation to be related to dose or infusion rate.
ing symptoms and to carry self-injectable
food, and skin prick testing (or sometimes § Although included here to prompt a adrenaline (EpiPen) (after being trained in its
intradermal testing), to assess allergy to medi- consideration of this underlying disease, use).
systemic mastocytosis is, strictly speaking, • Provision of a written anaphylaxis action
cations or insect venom, are more sensitive
a cause of anaphylaxis. ◆
than in-vitro testing. As these carry a small risk plan.
1 Stop administration of causative agent (if relevant), assess reaction severity and treat accordingly
IF HYPOTENSIVE, ALSO:
Set up additional wide-bore IV access (ie, 14G or 16G in adults) for normal saline infusion
Give IV normal saline bolus 20 mL/kg over 1–2 min under pressure
IM = intramuscular. IV = intravenous. Adapted with permission from: Brown SGA. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 2006; 18:
155-169.17 ◆
• Identification of at-risk patients with a MedicAlert bracelet 17 years of age. Even if an initial EpiPen injection has been
and entry of an allergy alert into hospital or health care network effective, patients should seek emergency medical care without
clinical information systems. delay. Patients who live or work in remote areas should consider
A number of resources for patients and health care professionals, having access to means of summoning emergency assistance, such
including guidelines for dealing with anaphylaxis in specific as a mobile telephone or, in some cases, an emergency satellite
settings such as schools and childcare centres, prescribing guide- beacon.
lines and written action plans, are available on the ASCIA website
(http://www.allergy.org.au/anaphylaxis). The EpiPen doses com-
monly recommended by specialist bodies (such as ASCIA) differ 7 Evidence-based practice tips*
from those in the package insert. ASCIA recommends prescribing • Recommended acute management of a patient with anaphylaxis
EpiPen Junior (0.15 mg) for patients weighing 10–20 kg and is to place the patient in a supine position and give adrenaline and
EpiPen (0.3 mg) for patients weighing over 20 kg. intravenous volume resuscitation (Level IV).1
Wearing a MedicAlert bracelet (Australia MedicAlert Founda- • Intramuscular injection into the lateral thigh (vastus lateralis) is
tion, Adelaide, SA) may give attending medical or paramedical preferred to injections into arm or deltoid muscles or
personnel access to additional information about known allergies, subcutaneously, because of better absorption (Level III-1).21,22
reduce the risk of administration of allergenic medication, and • A controlled intravenous infusion of adrenaline is a safe and
facilitate earlier recognition and treatment of anaphylaxis. effective management for anaphylaxis (Level III-3).18
Despite their widespread clinical use, medications such as • A reasonable length of observation after symptom resolution is
antihistamines and corticosteroids have no proven efficacy in 4–6 hours in most patients, with more prolonged observation
preventing or treating anything other than mild cutaneous allergic recommended in patients with severe or refractory symptoms
(Level IV).1
symptoms. Furthermore, the cost of maintaining or using these
medications in people with anaphylaxis due to other causes needs • Venom immunotherapy prevents anaphylaxis to insect stings and
to be balanced against the cost of purchasing an additional EpiPen. significantly improves quality of life compared with carrying
injectable adrenaline (EpiPen) alone (Level II).23,24
Large doses of adrenaline may be required to treat hypotensive
anaphylaxis,18 so Australians living in remote areas may need * Based on National Health and Medical Research Council levels of
additional supplies beyond the single EpiPen unit subsidised by evidence.25 ◆
the current Pharmaceutical Benefits Scheme for individuals over